Catalent has Acquired Delphi Genetics and Launches US Plasmid Manufacturing Site

Establishing global pDNA development and manufacturing capabilities to support cell and gene therapy programs from preclinical through to commercialization

Catalent on Track to Produce Over One Billion Doses of Covid-19 Vaccines and Therapies

Working on 80+ compounds for 60+ customers across our global network

Developing Biologic Drugs is Science.

Accelerating Advanced Treatments & Vaccines is Art.

Catalent has Acquired Delphi Genetics and Launches US Plasmid Manufacturing Site

Establishing global pDNA development and manufacturing capabilities to support cell and gene therapy programs from preclinical through to commercialization

Catalent on Track to Produce Over One Billion Doses of Covid-19 Vaccines and Therapies

Working on 80+ compounds for 60+ customers across our global network

Developing Biologic Drugs is Science.

Accelerating Advanced Treatments & Vaccines is Art.